BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34068561)

  • 1. The Therapeutic Potential of the Anticancer Activity of Fucoidan: Current Advances and Hurdles.
    Jin JO; Chauhan PS; Arukha AP; Chavda V; Dubey A; Yadav D
    Mar Drugs; 2021 May; 19(5):. PubMed ID: 34068561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Seaweeds in the Oncology Arena: Anti-Cancer Potential of Fucoidan as a Drug-A Review.
    Jin JO; Yadav D; Madhwani K; Puranik N; Chavda V; Song M
    Molecules; 2022 Sep; 27(18):. PubMed ID: 36144768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fucoidan and cancer: a multifunctional molecule with anti-tumor potential.
    Atashrazm F; Lowenthal RM; Woods GM; Holloway AF; Dickinson JL
    Mar Drugs; 2015 Apr; 13(4):2327-46. PubMed ID: 25874926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticancer properties and mechanisms of fucoidan on mouse breast cancer in vitro and in vivo.
    Xue M; Ge Y; Zhang J; Wang Q; Hou L; Liu Y; Sun L; Li Q
    PLoS One; 2012; 7(8):e43483. PubMed ID: 22916270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A review about the development of fucoidan in antitumor activity: Progress and challenges.
    Wu L; Sun J; Su X; Yu Q; Yu Q; Zhang P
    Carbohydr Polym; 2016 Dec; 154():96-111. PubMed ID: 27577901
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brown seaweed fucoidan: biological activity and apoptosis, growth signaling mechanism in cancer.
    Senthilkumar K; Manivasagan P; Venkatesan J; Kim SK
    Int J Biol Macromol; 2013 Sep; 60():366-74. PubMed ID: 23817097
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fucoidan as a marine anticancer agent in preclinical development.
    Kwak JY
    Mar Drugs; 2014 Jan; 12(2):851-70. PubMed ID: 24477286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The potential of brown-algae polysaccharides for the development of anticancer agents: An update on anticancer effects reported for fucoidan and laminaran.
    Sanjeewa KKA; Lee JS; Kim WS; Jeon YJ
    Carbohydr Polym; 2017 Dec; 177():451-459. PubMed ID: 28962791
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Fucoidan and Chemotherapeutic Agent Combinations on Malignant and Non-malignant Breast Cell Lines.
    Abudabbus A; Badmus JA; Shalaweh S; Bauer R; Hiss D
    Curr Pharm Biotechnol; 2017; 18(9):748-757. PubMed ID: 29141543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A review on fucoidan antitumor strategies: From a biological active agent to a structural component of fucoidan-based systems.
    Oliveira C; Neves NM; Reis RL; Martins A; Silva TH
    Carbohydr Polym; 2020 Jul; 239():116131. PubMed ID: 32414455
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fucoidan Structure and Its Impact on Glucose Metabolism: Implications for Diabetes and Cancer Therapy.
    Mabate B; Daub CD; Malgas S; Edkins AL; Pletschke BI
    Mar Drugs; 2021 Jan; 19(1):. PubMed ID: 33440853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of fucoidan on breast cancer cells and potential enhancement of their sensitivity to chemotherapy by regulating autophagy.
    Zhang N; Xue M; Wang Q; Liang H; Yang J; Pei Z; Qin K
    Phytother Res; 2021 Dec; 35(12):6904-6917. PubMed ID: 34687482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in cell death and cell cycle following fucoidan treatment in high-density HT-29 colon cancer cells.
    Kim IH; Kwon MJ; Nam TJ
    Mol Med Rep; 2017 Jun; 15(6):4116-4122. PubMed ID: 28487956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fucoidan Purified from
    Fernando IPS; Sanjeewa KKA; Lee HG; Kim HS; Vaas APJP; De Silva HIC; Nanayakkara CM; Abeytunga DTU; Lee DS; Lee JS; Jeon YJ
    Mar Drugs; 2020 Apr; 18(4):. PubMed ID: 32276359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The anti-cancer effects of fucoidan: a review of both in vivo and in vitro investigations.
    Lin Y; Qi X; Liu H; Xue K; Xu S; Tian Z
    Cancer Cell Int; 2020; 20():154. PubMed ID: 32410882
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fucoidan Structure and Activity in Relation to Anti-Cancer Mechanisms.
    van Weelden G; Bobiński M; Okła K; van Weelden WJ; Romano A; Pijnenborg JMA
    Mar Drugs; 2019 Jan; 17(1):. PubMed ID: 30621045
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fucoidan and Alginate from the Brown Algae
    Al Monla R; Dassouki Z; Sari-Chmayssem N; Mawlawi H; Gali-Muhtasib H
    Molecules; 2022 Jan; 27(2):. PubMed ID: 35056673
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic Effects of Fucoidan: A Review on Recent Studies.
    Luthuli S; Wu S; Cheng Y; Zheng X; Wu M; Tong H
    Mar Drugs; 2019 Aug; 17(9):. PubMed ID: 31438588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fucoidan-coated coral-like Pt nanoparticles for computed tomography-guided highly enhanced synergistic anticancer effect against drug-resistant breast cancer cells.
    Kang S; Kang K; Chae A; Kim YK; Jang H; Min DH
    Nanoscale; 2019 Aug; 11(32):15173-15183. PubMed ID: 31380881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fucoidan induces Toll-like receptor 4-regulated reactive oxygen species and promotes endoplasmic reticulum stress-mediated apoptosis in lung cancer.
    Hsu HY; Lin TY; Lu MK; Leng PJ; Tsao SM; Wu YC
    Sci Rep; 2017 Mar; 7():44990. PubMed ID: 28332554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.